These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34298409)

  • 1. Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome.
    Cinoku II; Verrou KM; Piperi E; Voulgarelis M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2021 Sep; 123():102704. PubMed ID: 34298409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
    Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
    J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
    Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
    J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma?
    Nezos A; Skarlis C; Psarrou A; Markakis K; Garantziotis P; Papanikolaou A; Gravani F; Voulgarelis M; Tzioufas AG; Koutsilieris M; Moutsopoulos HM; Kotsifaki E; Mavragani CP
    Front Immunol; 2021; 12():683623. PubMed ID: 34220834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
    Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
    Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome.
    Hall JC; Baer AN; Shah AA; Criswell LA; Shiboski CH; Rosen A; Casciola-Rosen L
    Arthritis Rheumatol; 2015 Sep; 67(9):2437-46. PubMed ID: 25988820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
    Jara D; Carvajal P; Castro I; Barrera MJ; Aguilera S; González S; Molina C; Hermoso M; González MJ
    Front Immunol; 2021; 12():685837. PubMed ID: 34149728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferons in Sjögren's syndrome.
    Yao Y; Liu Z; Jallal B; Shen N; Rönnblom L
    Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization.
    Jordan RC; Pringle JH; Speight PM
    J Pathol; 1995 Sep; 177(1):35-40. PubMed ID: 7472777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.
    Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG
    Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
    Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
    Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development.
    Jordan R; Diss TC; Lench NJ; Isaacson PG; Speight PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):723-9. PubMed ID: 7621030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
    Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
    Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection.
    Coll J; Gambús G; Corominas J; Tomás S; Esteban JI; Guardia J
    Ann Rheum Dis; 1997 Jun; 56(6):390-2. PubMed ID: 9227171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.